MADRIGAL PHARMACEUTICALS INC
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
MDGL$432.79+8.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31,2023 | December 31,2022 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $99,915 | $331,549 |
| Marketable securities | 534,216 | 27,225 |
| Prepaid expenses and other current assets | 3,150 | 2,595 |
| Total current assets | 637,281 | 361,369 |
| Property and equipment, net | 1,553 | 601 |
| Right-of-use asset | 1,713 | 602 |
| Total assets | $640,547 | $362,572 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $28,041 | $23,831 |
| Accrued expenses | 89,980 | 91,461 |
| Lease liability | 527 | 602 |
| Total current liabilities | 118,548 | 115,894 |
| Long term liabilities: | ||
| Loan payable, net of discount | 115,480 | 49,289 |
| Lease liability | 1,186 | — |
| Total long term liabilities | 116,666 | 49,289 |
| Total liabilities | 235,214 | 165,183 |
| Stockholders’ equity: | ||
| Preferred stock, par value $0.0001 per share authorized: 5,000,000 shares at December 31, 2023 and December 31, 2022; 2,369,797 and 2,369,797 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | — | — |
| Common stock, par value $0.0001 per share authorized: 200,000,000 at December 31, 2023 and December 31, 2022; 19,875,427 and 18,102,523 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | 2 | 2 |
| Additional paid-in-capital | 1,741,153 | 1,160,079 |
| Accumulated other comprehensive income (loss) | 468 | (32) |
| Accumulated deficit | (1,336,290) | (962,660) |
| Total stockholders’ equity | 405,333 | 197,389 |
| Total liabilities and stockholders’ equity | $640,547 | $362,572 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.